Ezequiel Mauro (@ezemauro_ok) 's Twitter Profile
Ezequiel Mauro

@ezemauro_ok

Hepatology - Liver Cancer - Liver Transplant.
Liver Unit - Hospital Clinic of Barcelona - IDIBAPS
Lover of medicine, chess, polo and roller hockey.

ID: 1248254528983531520

calendar_today09-04-2020 14:20:53

1,1K Tweet

767 Followers

1,1K Following

Paola Andrenacci (@paoandrenacci) 's Twitter Profile Photo

Muchas gracias Sociedad Argentina de Hepatologia por la invitación a participar como docente del Curso Superior 2025-2026. Especial agradecimiento a los Directores: ADRIAN NARVAEZ y Dr. Omar Galdame. Fue un honor participar junto a Ezequiel Mauro #livertwitter #nutrition

Muchas gracias <a href="/SAHEpatologia/">Sociedad Argentina de Hepatologia</a> por la invitación a participar como docente del Curso Superior 2025-2026.
Especial agradecimiento a los Directores: <a href="/ADNARVAEZ22/">ADRIAN NARVAEZ</a> y Dr. Omar Galdame. Fue un honor participar junto a <a href="/ezemauro_ok/">Ezequiel Mauro</a> #livertwitter #nutrition
Bishal Gyawali, MD, PhD, FASCO (@oncology_bg) 's Twitter Profile Photo

The most practice changing trial from #ASCO25 is now live on NEJM .If this was a drug, this would be approved today. Globally relevant and low-cost intervention that is not only delaying relapse but actually improving survival. Perfect case example of a #cancergroundshot trial.

The most practice changing trial from #ASCO25 is now live on <a href="/NEJM/">NEJM</a> .If this was a drug, this would be approved today. Globally relevant and low-cost intervention that is not only delaying relapse but actually improving survival. 
Perfect case example of a #cancergroundshot trial.
Beverly G. Tchang, MD (@bevtchangmd) 's Twitter Profile Photo

Semaglutide plus trevogrumab (myostatin inhibitor) preserves muscle mass in the setting of #weightloss over 26 wks Regeneron Combination vs sema alone: 👉 #Weight ⬇️11.3% vs ⬇️10.4% 👉 Muscle ⬇️4.2 lbs vs ⬇️7.9 lbs 👉 Fat ⬇️18.9 lbs vs ⬇️15.3 lbs newsroom.regeneron.com/news-releases/…

Asociación Española para el Estudio del Hígado (@aeehliver) 's Twitter Profile Photo

🟠Desarrollan un algoritmo que predice la respuesta al tratamiento en la cirrosis descompensada por hepatitis autoinmune. 👨‍🔬Así lo demuestra un estudio liderado por Maria Carlota Londoño y cuya primera firmante es Pinelopi Arvaniti del área de Enfermedades Hepáticas y Digestivas del #CIBEREHD,

🟠Desarrollan un algoritmo que predice la respuesta al tratamiento en la cirrosis descompensada por hepatitis autoinmune.
👨‍🔬Así lo demuestra un estudio liderado por <a href="/macarlotal/">Maria Carlota Londoño</a>  y cuya primera firmante es <a href="/Pi_Arvaniti/">Pinelopi Arvaniti</a> del área de Enfermedades Hepáticas y Digestivas del #CIBEREHD,
Cancers MDPI (@cancers_mdpi) 's Twitter Profile Photo

📢Today, we share the #Review "New Challenges in the Management of #Cholangiocarcinoma: The Role of Liver Transplantation, Locoregional Therapies, and Systemic Therapy" 🙌Citations: 29 👨‍🔬by Ezequiel Mauro, et al. IDIBAPS 📌Access the full paper here: mdpi.com/2072-6694/15/4…

📢Today, we share the #Review "New Challenges in the Management of #Cholangiocarcinoma: The Role of Liver Transplantation, Locoregional Therapies, and Systemic Therapy"
🙌Citations: 29
👨‍🔬by Ezequiel Mauro, et al. <a href="/idibaps/">IDIBAPS</a> 
📌Access the full paper here: mdpi.com/2072-6694/15/4…
Michael "Mike" Albert, MD (@michaelalbertmd) 's Twitter Profile Photo

🧠 Tirzepatide doesn’t just reduce appetite—it rewires the brain. - - - A new Nature Medicine Phase 1 RCT (n=114) explored how tirzepatide changes eating behavior—and the brain’s response to food—in people with overweight or obesity. 📉 Key Findings at 3–6 Weeks 🔹-524 kcal/day

🧠 Tirzepatide doesn’t just reduce appetite—it rewires the brain.
- - -
A new Nature Medicine Phase 1 RCT (n=114) explored how tirzepatide changes eating behavior—and the brain’s response to food—in people with overweight or obesity.

📉 Key Findings at 3–6 Weeks
🔹-524 kcal/day
Juan Manuel Díaz, MD, MSc (@juanmadiazach) 's Twitter Profile Photo

❤️ Does the heart whisper before the liver crashes? This editorial in Liver Transplantation Journal (LTxJournal) takes a closer look at NT-proBNP and how it might help predict ACLF and WL outcomes.Really interesting questions and reflections on our study. 📄 doi.org/10.1097/LVT.00… Ezequiel Mauro

Marios Georgakis (@mariosgeorgakis) 's Twitter Profile Photo

I read this Cell paper that argues to have discovered a molecule (betaine) that mimics the geroprotective effects of exercise. This is a very valuable multi-omics resource, but the authors seemed to get caught in the rabbit hole of chasing a high-impact narrative🧵

I read this Cell paper that argues to have discovered a molecule (betaine) that mimics the geroprotective effects of exercise.

This is a very valuable multi-omics resource, but the authors seemed to get caught in the rabbit hole of chasing a high-impact narrative🧵
Ramon Bataller (@rabataller) 's Twitter Profile Photo

Just released: the @USNews 2025 global rankings of the World’s Best Universities. Proud to share that we’re ranked #3 worldwide in Gastroenterology & Hepatology! Huge thanks to our clinicians, researchers, students, and staff—this recognition belongs to all of you.

Just released: the @USNews 2025 global rankings of the World’s Best Universities.

Proud to share that we’re ranked #3 worldwide in Gastroenterology &amp; Hepatology!

Huge thanks to our clinicians, researchers, students, and staff—this recognition belongs to all of you.
JAMA Oncology (@jamaonc) 's Twitter Profile Photo

RCT: Adjuvant therapy combining chemoradiation and camrelizumab improves overall and recurrence-free survival in patients with resectable extrahepatic cholangiocarcinoma and gallbladder cancer. ja.ma/44uCd1i

RCT: Adjuvant therapy combining chemoradiation and camrelizumab improves overall and recurrence-free survival in patients with resectable extrahepatic cholangiocarcinoma and gallbladder cancer. ja.ma/44uCd1i
Hospital Clínic (@hospitalclinic) 's Twitter Profile Photo

El #CLÍNIC és líder en trasplantaments de fetge a Catalunya: 🔷 Per activitat 🔷 Per supervivència 💪 Per això és centre de referència per a pacients d’alta complexitat i se centra en la innovació constant en tots els àmbits i la #recerca ➕ Info 👉 tinyurl.com/5n8hnzu3

El #CLÍNIC és líder en trasplantaments de fetge a Catalunya:

🔷 Per activitat
🔷 Per supervivència

💪 Per això és centre de referència per a pacients d’alta complexitat i se centra en la innovació constant en tots els àmbits i la #recerca

➕ Info 👉 tinyurl.com/5n8hnzu3
Ramon Bataller (@rabataller) 's Twitter Profile Photo

With deep sadness, we share the passing of Dr. Jaime Bosch — a visionary researcher, passionate physician, and cherished friend. Widely regarded as the father of portal hypertension, the Liver Unit of Barcelona will always be indebted to his immense legacy.

With deep sadness, we share the passing of Dr. Jaime Bosch — a visionary researcher, passionate physician, and cherished friend. 

Widely regarded as the father of portal hypertension, the Liver Unit of Barcelona will always be indebted to his immense legacy.
Massimo Colombo (@mcolombo46) 's Twitter Profile Photo

Professor Jaime Bosch a founder of modern hepatology passed away today. The world community of hepatologists is now missing not only a respected member of the academy but above all a strenuous defender of ethics in science and medicine,a passionate teacher and a superb mentor.

IDIBAPS (@idibaps) 's Twitter Profile Photo

🖤We are saddened by the passing of Jaume Bosch, a world-renowned expert in hepatology and key researcher at IDIBAPS. His legacy in portal hypertension and liver disease research will endure 👉f.mtr.cool/bjjakmgmea

🖤We are saddened by the passing of Jaume Bosch, a world-renowned expert in hepatology and key researcher at IDIBAPS. His legacy in portal hypertension and liver disease research will endure

👉f.mtr.cool/bjjakmgmea
EASLnews (@easlnews) 's Twitter Profile Photo

The authors of today’s #readoftheweek📚 discuss the use of invasive coronary angiography in #livertransplant candidates. Read here this JHEP Reports article: jhep-reports.eu/article/S2589-… 🙏Giulia Pagano, Salvatore Brugaletta, Ander Regueiro, Jordi Colmenero, Gonzalo Crespo et al. #LiverX

The authors of today’s #readoftheweek📚 discuss the use of invasive coronary angiography in #livertransplant candidates.

Read here this <a href="/JHEP_Reports/">JHEP Reports</a> article: jhep-reports.eu/article/S2589-…

🙏<a href="/Giulia76907046/">Giulia Pagano</a>, <a href="/sbrugaletta/">Salvatore Brugaletta</a>, <a href="/AnderRegueiro/">Ander Regueiro</a>, <a href="/ColmeneroJordi/">Jordi Colmenero</a>, <a href="/goncrespo1/">Gonzalo Crespo</a> et al.

#LiverX